COVID-19 Vaccine

On Sunday, several media reports suggested that Russia has become the first nation to complete clinical trials of a COVID-19 vaccine on humans.

While the initial results of human trials do indicate that the vaccine is safe and effective to an extent, celebrating the supposed ‘world’s first COVID-19 vaccine’ seems premature.

On June 18, Russia allowed clinical trials of two forms of a potential COVID-19 vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology.

The first vaccine, in the form of a solution for intramuscular administration, was carried out at the Burdenko Military Hospital.
Another vaccine, in the form of a powder for the preparation of a solution for intramuscular administration, was carried out at Sechenov First Moscow State Medical University.

The first stage of research on the vaccine at Sechenov University involved a group of 18 volunteers, and the second group comprised 20 volunteers. After vaccination, all volunteers were expected to remain in isolation in a hospital for 28 days.

Even though the Russian vaccine has cleared the first phase of clinical trials, it has a long way ahead to be recognised as a proven vaccine against COVID-19.
.
.
.
#covid19#coronavirus#covidvaccine#covid_19#corona#health#vaccine#healthnews#environment#environmentnews#weather

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s